Why Did We Lead a $6M Investment Round With Genoox?

Prior to our Genoox investment, we had never invested in the medical field. Our ability to serve as an expert in the space our investments occupy is fundamental for us as a venture capital fund. For years, we never feared denying a company an investment even if we were certain the company would succeed, with the only reason being that they weren’t operating in a field in which we could use our expertise to its fullest effect. So what is different this time? Why did we deviate from our standard practice? And why specifically with Genoox?